↓ Skip to main content

Cancer vaccines as promising immuno-therapeutics: platforms and current progress

Overview of attention for article published in Journal of Hematology & Oncology, March 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
2 news outlets
twitter
26 X users
facebook
1 Facebook page

Citations

dimensions_citation
248 Dimensions

Readers on

mendeley
435 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Published in
Journal of Hematology & Oncology, March 2022
DOI 10.1186/s13045-022-01247-x
Pubmed ID
Authors

Jian Liu, Minyang Fu, Manni Wang, Dandan Wan, Yuquan Wei, Xiawei Wei

X Demographics

X Demographics

The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 435 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 435 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 56 13%
Student > Bachelor 43 10%
Student > Master 41 9%
Researcher 24 6%
Student > Doctoral Student 14 3%
Other 44 10%
Unknown 213 49%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 62 14%
Medicine and Dentistry 35 8%
Immunology and Microbiology 26 6%
Pharmacology, Toxicology and Pharmaceutical Science 22 5%
Agricultural and Biological Sciences 14 3%
Other 53 12%
Unknown 223 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 36. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2024.
All research outputs
#1,127,164
of 25,837,817 outputs
Outputs from Journal of Hematology & Oncology
#55
of 1,307 outputs
Outputs of similar age
#28,348
of 462,619 outputs
Outputs of similar age from Journal of Hematology & Oncology
#2
of 26 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,307 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.5. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 462,619 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.